Most Read Articles
Christina Lau, 2 years ago
A large study that tracked anticholinergic drug use over 10 years provides the strongest evidence to date on the association between these commonly used drugs and dementia in older adults. 
one year ago
Both carbamazepine and valproate do not increase cardiovascular risks in epileptic children on long-term monotherapy and three months following discontinuation of drug based on results of a study.
one year ago
Donepezil at an increased dosage of 10 mg/day is safe and effective for patients with dementia with Lewy bodies experiencing a relapse of behavioural and psychological symptoms of dementia, an open-label trial demonstrated.
Dr. Joslyn Ngu, one year ago
A nationwide study showed that one in four persons had presentations of early nerve damage, while a survey in the Klang Valley found it occurred in one in two adults above the age of 21 years.

Excerpts from the Inaugural Meeting of the Dementia Advisory Board Malaysia

one year ago
This article presents the excerpts from the Inaugural Meeting of the Dementia Advisory Board Malaysia held on 23 January 2016 in Kuala Lumpur, highlighting the clinical evidence of Ginkgo biloba extract EGb761® in dementia, treatment recommendations from international guidelines and consensus reached during the meeting on the role of EGb761® in managing dementia.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Christina Lau, 2 years ago
A large study that tracked anticholinergic drug use over 10 years provides the strongest evidence to date on the association between these commonly used drugs and dementia in older adults. 
one year ago
Both carbamazepine and valproate do not increase cardiovascular risks in epileptic children on long-term monotherapy and three months following discontinuation of drug based on results of a study.
one year ago
Donepezil at an increased dosage of 10 mg/day is safe and effective for patients with dementia with Lewy bodies experiencing a relapse of behavioural and psychological symptoms of dementia, an open-label trial demonstrated.
Dr. Joslyn Ngu, one year ago
A nationwide study showed that one in four persons had presentations of early nerve damage, while a survey in the Klang Valley found it occurred in one in two adults above the age of 21 years.